Showing results (131-140 of 324) with videos related to
Sort By:
Pageof 33
Biophysical Chemistry|June 2, 2009
The HSP90 binding mode of a radicicol-like E-oxime determined by docking, binding free energy estimations, and NMR 15N chemical shiftsMartin Spichty, Antoine Taly, Franz Hagn, et al.Current Pharmaceutical Design|July 23, 2003
Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivoUte Reuning, Stefan Sperl, Charlotte Kopitz, et al.Small (Weinheim an Der Bergstrasse, Germany)|August 21, 2007
Specific integrin labeling in living cells using functionalized nanocrystalsOliver Lieleg, Mónica López-García, Christine Semmrich, et al.Organic Letters|July 19, 2002
Synthesis and NMR studies of cyclopeptides containing a sugar amino AcidMatthias Stöckle, Georg Voll, Robert Günther, et al.EJNMMI Research|August 15, 2019
Validation of [125I]CPCR4.3 as an investigative tool for the sensitive and specific detection of hCXCR4 and mCXCR4 expression in vitro and in vivoMargret Schottelius, Marina Ludescher, Frauke Richter, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|October 2, 2002
Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acidsSibylle A W Gruner, Vincent Truffault, Georg Voll, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|June 22, 2006
Synthesis and stereochemical assignment of DNA spore photoproduct analoguesMarcus G Friedel, J Carsten Pieck, Jochen Klages, et al.Frontiers in Oncology|September 7, 2013
Tumor Targeting via Integrin LigandsUdaya Kiran Marelli, Florian Rechenmacher, Tariq Rashad Ali Sobahi, et al.Nano Letters|January 8, 2020
Integrin Subtypes and Nanoscale Ligand Presentation Influence Drug Sensitivity in Cancer CellsJennifer L Young, Ximeng Hua, Heidi Somsel, et al.The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|April 22, 2020
Robotic radical hysterectomy for stage 1B1 cervical cancer: A case series of survival outcomes from a leading UK cancer centreHersha Patel, Kavitha Madhuri, Thomas Rockell, et al.Pageof 33